Position in GILD
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$817,040
-$135,135 QoQ
Shares Held
6,467
-5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#1,159
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Greenwich Wealth Management LLC holds $17,338,236 across 10 Drug Manufacturers - General names. GILD ranks #8 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
14,267 | $3,590,147 | |
| 2 | PFE |
Pfizer Inc
|
140,297 | $3,378,351 | |
| 3 | LLY |
ELI LILLY & Co
|
2,759 | $3,309,227 | |
| 4 | NVS |
Novartis AG
|
11,294 | $1,769,995 | |
| 5 | GSK |
GSK plc
|
31,884 | $1,671,359 | |
| 6 | JNJ |
Johnson & Johnson
|
4,468 | $1,134,737 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,081 | $909,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
6,467 | $817,040 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $817,040 | 6,467 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $952,175 | 6,832 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $799,160 | 6,511 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $752,025 | 6,775 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $694,157 | 6,261 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $732,134 | 6,534 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $622,389 | 6,738 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $583,274 | 6,957 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $527,130 | 7,683 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $540,878 | 7,384 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $569,500 | 7,030 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $534,621 | 7,134 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $522,303 | 6,777 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $536,152 | 6,462 | Shares | Sole | 2023-04-24 | |
| 2022-12-31 | $608,333 | 7,086 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $457,493 | 7,416 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $491,451 | 7,951 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $473,935 | 7,972 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $579,790 | 7,985 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $435,235 | 6,231 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $368,332 | 5,349 | Shares | Sole | 2021-07-27 | |
| 2021-03-31 | $384,419 | 5,948 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $352,706 | 6,054 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $388,618 | 6,150 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $463,255 | 6,021 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $422,244 | 5,648 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||